Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00954746 · ClinicalTrials.gov registry record
Longterm Observational Study in Subjects Treated With AA4500 in AUX-CC-854, 856, 857, 858 & 859
A clinical trial, sponsored by Endo USA Inc., a Keenova Therapeutics Company.
- Completed
- Registry status
- 645
- Enrollment target
NCT00954746: Completed study, sponsored by Endo USA Inc., a Keenova Therapeutics Company.
NCT00954746 is a clinical trial that has completed, run by Endo USA Inc., a Keenova Therapeutics Company. The registered enrollment target is 645 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00954746 has completed, sponsored by Endo USA Inc., a Keenova Therapeutics Company.
- COMPLETED
- Registry status
- 645 participants
- Enrollment target
Study Summary
The purpose of study AUX-CC-860 is to assess the durability of response of the AA4500 treatment regimen. This study will also evaluate long-term safety and progression of disease in joints.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 645 participants |
| Start Date | 2009-07 |
| Est. Completion | 2013-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00954746
The ClinicalTrials.gov registry entry for NCT00954746 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 645 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Endo USA Inc., a Keenova Therapeutics Company, which has 61 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00954746 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00954746 about?
NCT00954746 is a clinical study titled "Longterm Observational Study in Subjects Treated With AA4500 in AUX-CC-854, 856, 857, 858 & 859". The purpose of study AUX-CC-860 is to assess the durability of response of the AA4500 treatment regimen. This study will also evaluate long-term safety and progression of disease in joints.
What is the current status of trial NCT00954746?
This trial is currently completed. The enrollment target is 645 participants. The study started on 2009-07. Estimated completion is 2013-05.
Who is sponsoring clinical trial NCT00954746?
This trial is sponsored by Endo USA Inc., a Keenova Therapeutics Company, which has 61 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.